目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED & REGIONAL SCOPE
1.3.2 INCLUSIONS & EXCLUSIONS
1.4 YEARS CONSIDERED
1.5 CURRENCY USED
1.6 UNIT CONSIDERED
1.7 STAKEHOLDERS
1.8 LIMITATIONS

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.2 RESEARCH DESIGN
2.2.1 SECONDARY RESEARCH
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY RESEARCH
2.2.2.1 Primary sources
2.2.2.2 Key industry insights
2.2.2.3 Breakdown of primary interviews
2.3 MARKET SIZE ESTIMATION
2.3.1 SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS)
2.3.2 BOTTOM-UP APPROACH
2.3.2.1 Company revenue estimation approach
2.3.2.2 Customer-based market estimation
2.3.2.3 Demand-side analysis
2.3.2.4 Growth forecast approach
2.4 DATA TRIANGULATION
2.5 MARKET SHARE ASSESSMENT
2.6 RESEARCH ASSUMPTIONS
2.7 RESEARCH LIMITATIONS
2.8 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS
4.1 SINGLE-USE SURGICAL INSTRUMENTS MARKET OVERVIEW
4.2 ASIA PACIFIC: SINGLE-USE SURGICAL INSTRUMENTS MARKET, BY PRODUCT TYPE AND COUNTRY (2024)
4.3 SINGLE-USE SURGICAL INSTRUMENTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.4 SINGLE-USE SURGICAL INSTRUMENTS MARKET: REGIONAL MIX
4.5 SINGLE-USE SURGICAL INSTRUMENTS MARKET: DEVELOPED VS. DEVELOPING ECONOMIES

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing prevalence of chronic diseases
5.2.1.2 Growing number of surgical procedures
5.2.1.3 Increased focus on safety and infection control
5.2.1.4 Technological advancements
5.2.2 RESTRAINTS
5.2.2.1 High cost associated with single-use instruments
5.2.2.2 Regulatory and quality control challenges
5.2.3 OPPORTUNITIES
5.2.3.1 Expansion of healthcare infrastructure in emerging markets
5.2.4 CHALLENGES
5.2.4.1 Environmental sustainability and waste management
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
5.4 PRICING ANALYSIS
5.4.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT TYPE, 2024
5.4.2 AVERAGE SELLING PRICE TREND OF FORCEPS, BY REGION, 2022-2024 (USD)
5.5 VALUE CHAIN ANALYSIS
5.6 SUPPLY CHAIN ANALYSIS
5.7 ECOSYSTEM ANALYSIS
5.8 INVESTMENT & FUNDING SCENARIO
5.9 TECHNOLOGY ANALYSIS
5.9.1 KEY TECHNOLOGIES
5.9.1.1 Injection molding of medical-grade polymers
5.9.2 COMPLEMENTARY TECHNOLOGIES
5.9.2.1 Ergonomic design software to optimize instrument shape
5.9.3 ADJACENT TECHNOLOGIES
5.9.3.1 Robotic-assisted surgical tools
5.10 INDUSTRY TRENDS
5.10.1 INTEGRATION OF ADVANCED MATERIALS AND SUSTAINABILITY INITIATIVES
5.11 PATENT ANALYSIS
5.12 TRADE ANALYSIS
5.12.1 IMPORT DATA (HS CODE 901890)
5.12.2 EXPORT DATA (HS CODE 901890)
5.13 KEY CONFERENCES & EVENTS, 2025-2026
5.14 CASE STUDY ANALYSIS
5.14.1 CASE STUDY 1: ADOPTION OF SINGLE-USE SURGICAL INSTRUMENTS IN OPHTHALMIC SURGERIES
5.14.2 CASE STUDY 2: SSI REDUCTION IN ORTHOPEDIC SURGERY THROUGH THE USE OF SINGLE-USE IMPLANTS
5.14.3 CASE STUDY 3: REDUCED SSI RATES IN CESAREAN SECTIONS USING SINGLE-USE INSTRUMENTS IN LOW-RESOURCE SETTINGS
5.15 REGULATORY ANALYSIS
5.15.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.15.2 REGULATORY LANDSCAPE
5.15.2.1 North America
5.15.2.1.1 US
5.15.2.1.2 Canada
5.15.2.2 Europe
5.15.2.3 Asia Pacific
5.15.2.3.1 China
5.15.2.3.2 Japan
5.15.2.3.3 India
5.15.2.4 Latin America
5.15.2.4.1 Brazil
5.15.2.4.2 Mexico
5.15.2.5 Middle East
5.15.2.6 Africa
5.16 PORTER'S FIVE FORCES ANALYSIS
5.16.1 BARGAINING POWER OF SUPPLIERS
5.16.2 BARGAINING POWER OF BUYERS
5.16.3 THREAT OF NEW ENTRANTS
5.16.4 THREAT OF SUBSTITUTES
5.16.5 INTENSITY OF COMPETITIVE RIVALRY
5.17 KEY STAKEHOLDERS & BUYING CRITERIA
5.17.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.17.2 BUYING CRITERIA
5.18 UNMET NEEDS/END-USER EXPECTATIONS
5.19 IMPACT OF 2025 US TARIFF ON SINGLE-USE SURGICAL INSTRUMENTS MARKET
5.19.1 KEY TARIFF RATES
5.19.2 PRICE IMPACT ANALYSIS
5.19.3 IMPACT ON END-USER INDUSTRIES
5.20 ADJACENT MARKET ANALYSIS

6 SINGLE-USE SURGICAL INSTRUMENTS MARKET, BY PRODUCT TYPE
6.1 INTRODUCTION
6.2 HANDHELD SURGICAL INSTRUMENTS
6.2.1 SCALPELS
6.2.1.1 Infection control priorities and outpatient surgery growth to drive demand for single-use surgical scalpels
6.2.2 FORCEPS
6.2.2.1 Shift to minimally invasive surgeries to accelerate adoption of single-use surgical forceps
6.2.3 SCISSORS
6.2.3.1 Surging surgical volumes to drive demand for single-use surgical scissors
6.2.4 OTHER HANDHELD SURGICAL INSTRUMENTS
6.3 ELECTROSURGICAL INSTRUMENTS
6.3.1 CAUTERY DEVICES
6.3.1.1 Sterility requirements to fuel growth in single-use cautery devices market
6.3.2 BIPOLAR FORCEPS
6.3.2.1 Growing preference for minimally invasive and robotic-assisted surgeries to boost market growth
6.3.3 OTHER ELECTROSURGICAL INSTRUMENTS
6.4 ENDOSCOPIC INSTRUMENTS
6.4.1 SINGLE-USE TROCARS
6.4.1.1 Rising adoption of minimally invasive surgeries and infection prevention imperatives to fuel growth
6.4.2 GRASPERS
6.4.2.1 Increasing demand for sterile, efficient solutions in minimally invasive surgeries to boost growth
6.4.3 OTHER ENDOSCOPIC INSTRUMENTS
6.5 OTHER SINGLE-USE SURGICAL INSTRUMENTS

7 SINGLE-USE SURGICAL INSTRUMENTS MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 GENERAL SURGERY
7.2.1 GROWING NEED FOR ENHANCED INFECTION CONTROL TO BOOST ADOPTION OF SINGLE-USE INSTRUMENTS IN GENERAL SURGERY
7.3 ORTHOPEDIC SURGERY
7.3.1 GROWING PREVALENCE OF OSTEOARTHRITIS AND SPORTS INJURIES TO BOOST MARKET GROWTH
7.4 CARDIOVASCULAR SURGERY
7.4.1 INCREASING INCIDENCE OF CARDIOVASCULAR DISEASES TO INCREASE NEED FOR CARDIAC INTERVENTION
7.5 GYNECOLOGY & OBSTETRICS SURGERY
7.5.1 INCREASING USE OF SUSI IN GYNECOLOGIC AND OBSTETRIC PROCEDURES TO ENSURE STERILITY TO DRIVE GROWTH
7.6 ENT SURGERY
7.6.1 INCREASING CASES OF ENT-RELATED DISORDERS TO BOOST DEMAND FOR SINGLE-USE SURGICAL INSTRUMENTS
7.7 OPHTHALMIC SURGERY
7.7.1 INNOVATIONS IN MICRO-INSTRUMENTATION TO BOLSTER MARKET
7.8 OTHER APPLICATIONS

8 SINGLE-USE SURGICAL INSTRUMENTS MARKET, BY CARE SETTING
8.1 INTRODUCTION
8.2 HOSPITALS & SPECIALTY CLINICS
8.2.1 HIGH VOLUME AND COMPLEXITY OF SURGERIES PERFORMED IN HOSPITALS TO DRIVE MARKET GROWTH
8.3 AMBULATORY SURGICAL CENTERS
8.3.1 SHIFT TOWARD OUTPATIENT SURGERIES TO CONTRIBUTE TO MARKET GROWTH
8.4 HOME CARE SETTINGS
8.4.1 GROWING PREFERENCE FOR HOME-BASED CARE TO BOOST DEMAND FOR SINGLE-USE SURGICAL INSTRUMENTS

9 SINGLE-USE SURGICAL INSTRUMENTS MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
9.2.2 US
9.2.2.1 Favorable infrastructure network to drive market
9.2.3 CANADA
9.2.3.1 Growing surgical volumes to fuel market
9.3 EUROPE
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
9.3.2 GERMANY
9.3.2.1 Rising healthcare spending to increase demand for single-use surgical instruments
9.3.3 UK
9.3.3.1 Growing focus on high-quality care at licensed fertility clinics to propel market
9.3.4 FRANCE
9.3.4.1 Rising elderly population to boost market
9.3.5 ITALY
9.3.5.1 Regulatory guidelines to govern market
9.3.6 SPAIN
9.3.6.1 Booming medical tourism to drive market
9.3.7 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
9.4.2 CHINA
9.4.2.1 Increasing medical benefits to drive market
9.4.3 JAPAN
9.4.3.1 Higher adoption of minimally invasive procedures to support market growth
9.4.4 INDIA
9.4.4.1 Affordable treatment options to fuel market
9.4.5 AUSTRALIA
9.4.5.1 Rise in chronic diseases to propel market
9.4.6 SOUTH KOREA
9.4.6.1 Growing focus on reversing low population trend to stimulate growth
9.4.7 REST OF ASIA PACIFIC
9.5 LATIN AMERICA
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
9.5.2 BRAZIL
9.5.2.1 Increasing volume of surgical procedures to stimulate growth
9.5.3 MEXICO
9.5.3.1 Expansion of healthcare infrastructure to aid market growth
9.5.4 REST OF LATIN AMERICA
9.6 MIDDLE EAST & AFRICA
9.6.1 RISING HEALTHCARE SPENDING TO DRIVE MARKET
9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
9.7 GCC COUNTRIES
9.7.1 IMPROVING HEALTH INFRASTRUCTURE TO PROPEL MARKET
9.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021-2025
10.3 REVENUE ANALYSIS, 2020-2024
10.4 MARKET SHARE ANALYSIS, 2024
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
10.5.5.1 Company footprint
10.5.5.2 Region footprint
10.5.5.3 Product type footprint
10.5.5.4 Application footprint
10.5.5.5 Care setting footprint
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
10.6.1 PROGRESSIVE COMPANIES
10.6.2 RESPONSIVE COMPANIES
10.6.3 DYNAMIC COMPANIES
10.6.4 STARTING BLOCKS
10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
10.6.5.1 Detailed list of key startups/SMEs
10.6.5.2 Competitive benchmarking of key startups/SMEs
10.7 COMPANY VALUATION AND FINANCIAL METRICS
10.7.1 FINANCIAL METRICS
10.7.2 COMPANY VALUATION
10.8 BRAND/PRODUCT COMPARISON
10.9 COMPETITIVE SCENARIO
10.9.1 PRODUCT LAUNCHES
10.9.2 DEALS
10.9.3 EXPANSIONS
10.9.4 OTHER DEVELOPMENTS

11 COMPANY PROFILES
11.1 KEY PLAYERS
11.1.1 JOHNSON & JOHNSON SERVICES, INC. (ETHICON, INC.)
11.1.1.1 Business overview
11.1.1.2 Products offered
11.1.1.3 MnM view
11.1.1.3.1 Right to win
11.1.1.3.2 Strategic choices
11.1.1.3.3 Weaknesses and competitive threats
11.1.2 MEDTRONIC
11.1.2.1 Business overview
11.1.2.2 Products offered
11.1.2.3 MnM view
11.1.2.3.1 Right to win
11.1.2.3.2 Strategic choices
11.1.2.3.3 Weaknesses and competitive threats
11.1.3 BD
11.1.3.1 Business overview
11.1.3.2 Products offered
11.1.3.3 MnM view
11.1.3.3.1 Right to win
11.1.3.3.2 Strategic choices
11.1.3.3.3 Weaknesses and competitive threats
11.1.4 B. BRAUN SE
11.1.4.1 Business overview
11.1.4.2 Products offered
11.1.4.3 MnM view
11.1.4.3.1 Right to win
11.1.4.3.2 Strategic choices
11.1.4.3.3 Weaknesses and competitive threats
11.1.5 SMITH+NEPHEW
11.1.5.1 Business overview
11.1.5.2 Products offered
11.1.5.3 Recent developments
11.1.5.3.1 Expansions
11.1.5.3.2 Other developments
11.1.5.4 MnM view
11.1.5.4.1 Right to win
11.1.5.4.2 Strategic choices
11.1.5.4.3 Weaknesses and competitive threats
11.1.6 COOPERSURGICAL, INC.
11.1.6.1 Business overview
11.1.6.2 Products offered
11.1.7 STRYKER
11.1.7.1 Business overview
11.1.7.2 Products offered
11.1.8 ALCON LABORATORIES, INC.
11.1.8.1 Business overview
11.1.8.2 Products offered
11.1.9 STERIS
11.1.9.1 Business overview
11.1.9.2 Products offered
11.1.9.3 Recent developments
11.1.9.3.1 Deals
11.1.10 PAUL HARTMANN AG
11.1.10.1 Business overview
11.1.10.2 Products offered
11.1.10.3 Recent developments
11.1.10.3.1 Deals
11.1.11 ERBE ELEKTROMEDIZIN GMBH
11.1.11.1 Business overview
11.1.11.2 Products offered
11.1.11.3 Recent developments
11.1.11.3.1 Product launches
11.1.11.3.2 Expansions
11.1.12 KIRWAN SURGICAL PRODUCTS, LLC
11.1.12.1 Business overview
11.1.12.2 Products offered
11.1.13 ASPEN SURGICAL PRODUCTS, INC.
11.1.13.1 Business overview
11.1.13.2 Products offered
11.1.13.3 Recent developments
11.1.13.3.1 Deals
11.1.14 SRR SURGICAL CO.
11.1.14.1 Business overview
11.1.14.2 Products offered
11.1.15 TATA SURGICAL
11.1.15.1 Business overview
11.1.15.2 Products offered
11.2 OTHER COMPANIES
11.2.1 DTR MEDICAL LTD.
11.2.2 FUHRMANN GMBH
11.2.3 HEINZ HERENZ
11.2.4 SWANN-MORTON LIMITED
11.2.5 PURPLE SURGICAL
11.2.6 SURGAID MEDICAL (XIAMEN) CO., LTD.
11.2.7 HANGZHOU TONGLU SHIKONGHOU MEDICAL INSTRUMENT CO., LTD.
11.2.8 TAKTVOLL
11.2.9 TIANJIN ZHICHAO MEDICAL TECHNOLOGY CO., LTD.
11.2.10 HANGZHOU SCONOR MEDICAL TECHNOLOGY CO., LTD.

12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS